Literature DB >> 14659739

Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents.

Jianbing Zhang1, Jamshid Tanha, Tomoko Hirama, Nam Huan Khieu, Rebecca To, Hong Tong-Sevinc, Emily Stone, Jean Robert Brisson, C Roger MacKenzie.   

Abstract

We describe a novel type of molecule in which single-domain antibodies (sdAbs) isolated from a nai;ve llama single domain antibody library are linked to an oligomerization domain to generate high-avidity, antigen-binding reagents. An sdAb is fused to the B-subunit of Escherichia coli verotoxin, or shiga-like toxin, which self-assembles to form a homopentamer and results in simultaneous sdAb pentamerization and introduction of avidity. Molecular modeling indicated that this fusion protein (PDB: 1OJF), termed pentabody, has structural flexibility for binding to surface-presented antigen. In the instance of an sdAb specific for a peptide antigen, pentamerization resulted in a dramatic increase in functional affinity for immobilized antigen. The pentabody was expressed in high yield in E.coli in a non-aggregated state, and exhibited excellent thermostability and protease resistance. This technology provides a relatively rapid means of generating novel antigen-binding molecules that bind strongly to immobilized antigen. It is expected that pentavalent sdAbs will have general applicability in proteomics, immunochemical staining, cancer diagnosis and other applications in which antigens are presented multivalently.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14659739     DOI: 10.1016/j.jmb.2003.09.034

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

1.  CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells.

Authors:  Sven Jähnichen; Christophe Blanchetot; David Maussang; Maria Gonzalez-Pajuelo; Ken Y Chow; Leontien Bosch; Sindi De Vrieze; Benedikte Serruys; Hans Ulrichts; Wesly Vandevelde; Michael Saunders; Hans J De Haard; Dominique Schols; Rob Leurs; Peter Vanlandschoot; Theo Verrips; Martine J Smit
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

2.  Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic.

Authors:  Qing Li; Christopher R So; Adrian Fegan; Vivian Cody; Mehmet Sarikaya; Daniel A Vallera; Carston R Wagner
Journal:  J Am Chem Soc       Date:  2010-11-15       Impact factor: 15.419

3.  An Ultrasensitive Bioluminescent Enzyme Immunoassay Based on Nanobody/Nanoluciferase Heptamer Fusion for the Detection of Tetrabromobisphenol A in Sediment.

Authors:  Zhenfeng Li; Yi Wang; Natalia Vasylieva; Debin Wan; Zihan Yin; Jiexian Dong; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-07-07       Impact factor: 6.986

4.  Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.

Authors:  Amanda Sparkes; Patrick De Baetselier; Lea Brys; Inês Cabrito; Yann G-J Sterckx; Steve Schoonooghe; Serge Muyldermans; Geert Raes; Richard Bucala; Peter Vanlandschoot; Jo A Van Ginderachter; Benoît Stijlemans
Journal:  FASEB J       Date:  2018-01-25       Impact factor: 5.191

5.  Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response.

Authors:  Sofia Tabares-da Rosa; Martin Rossotti; Carmen Carleiza; Federico Carrión; Otto Pritsch; Ki Chang Ahn; Jerold A Last; Bruce D Hammock; Gualberto González-Sapienza
Journal:  Anal Chem       Date:  2011-08-29       Impact factor: 6.986

6.  One-step immunoassay for tetrabromobisphenol a using a camelid single domain antibody-alkaline phosphatase fusion protein.

Authors:  Jia Wang; Zuzana Majkova; Candace R S Bever; Jun Yang; Shirley J Gee; Ji Li; Ting Xu; Bruce D Hammock
Journal:  Anal Chem       Date:  2015-04-22       Impact factor: 6.986

Review 7.  Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Differential recognition of vascular and parenchymal beta amyloid deposition.

Authors:  Kim S Rutgers; Alexandra van Remoortere; Mark A van Buchem; C Theo Verrips; Steven M Greenberg; Brian J Bacskai; Matthew P Frosch; Sjoerd G van Duinen; Marion L Maat-Schieman; Silvère M van der Maarel
Journal:  Neurobiol Aging       Date:  2009-12-16       Impact factor: 4.673

9.  Development of a one-step immunoassay for triazophos using camel single-domain antibody-alkaline phosphatase fusion protein.

Authors:  Kai Wang; Zhiping Liu; Guochun Ding; Ji Li; Natalia Vasylieva; Qing X Li; Dongyang Li; Shirley J Gee; Bruce D Hammock; Ting Xu
Journal:  Anal Bioanal Chem       Date:  2019-02-01       Impact factor: 4.142

10.  Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies.

Authors:  U Iqbal; H Albaghdadi; Y Luo; M Arbabi; C Desvaux; T Veres; D Stanimirovic; A Abulrob
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.